AVD AMERICAN VANGUARD CORP
8-K Current Report
Filed: March 19, 2026
Health Care
Agricultural ChemicalsAMERICAN VANGUARD CORP (AVD) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items3 items
- Item 1.01: Entry into a Material Definitive Agreement
- Item 1.02: Termination of a Material Definitive Agreement
- Item 2.03: Creation of a Direct Financial Obligation
AI Filing Analysis8-K
Item 1.01 · Entry into a Material Definitive Agreement
- • Amendment and restatement of Prior Credit Agreement with BMO Bank, N.A. as agent effective August 5, 2021
- • Replacement of Prior Credit Agreement with new Term Loans to refinance existing indebtedness
Item 1.02 · Termination of a Material Definitive Agreement
- • Termination of Prior Credit Agreement on March 13, 2026, indicates refinancing or restructuring of debt obligations
- • Entry into new Term Loans suggests new borrowing with potentially different terms and maturity
Item 2.03 · Creation of a Direct Financial Obligation
- • Filed new Credit and Guaranty Agreements dated March 13, 2026, indicating recent financing arrangements for American Vanguard and AMVAC Chemical
- • Agreements involve Wilmington Trust and BMO Bank N.A. as administrative and lead agents, signaling a syndicated loan structure
Other AMERICAN VANGUARD CORP 8-K Filings
Get deeper insights on AMERICAN VANGUARD CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.